[vc_row][vc_column][vc_separator][vc_column_text]Folsom, Calif. – To continue to provide new products and services to further advance medical research around the world, StemExpress announces the release of NEW Frozen Leukopak.
StemExpress Leukopaks, collected fresh and then immediately frozen, provide an enriched source of peripheral blood mononuclear cells (PBMCs) that can be used in a variety of medical research areas such as cancer, autoimmune diseases, device development, and more.
“Although we are widely known for same-day delivery of fresh biospecimen products from one of our multiple collection sites, we understand that the need for frozen products can be very beneficial to both our US-based and international partners,” said Matt Phillips, vice president of sales and marketing.
Shipping of fresh biospecimen products over long distances can be stressful on cells and compromise their quality. The new format, frozen directly after donor collection, will provide high-quality cells with increased flexibility of use.
Additionally, this new format can be customized per client request. For example, one Leukopak can be split, frozen, and shipped to multiple laboratories involved in the same study or to compare laboratory staff competencies, equipment functionality, and data analysis and reporting.
For more information regarding the release of NEW Frozen Leukopak, visit https://cgt.global/frozen-leukopak/ or call 530-303-3828.
About StemExpress, LLC
Headquartered in Folsom, CA, StemExpress is the leading global Biospecimen provider of human primary cells and blood products. StemExpress has a reliable and streamlined process starting with donor recruitment to shipping the final product guaranteeing every sample has the highest purity, viability, and quality.[/vc_column_text][vc_row_inner][vc_column_inner width=”1/2″][vc_column_text]Media Release
For Immediate Release
June 4, 2019[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Contact: Katherine Elorduy